Pre-clinical myocardial metabolic alterations in chronic kidney disease

Cardiology

Volumn 116, Issue 3, 2010, Pages 160-167

  Fink, Jeffrey C ^a   Lodge, Martin A ^b   Smith, Mark F ^a   Hinduja, Anish ^a   Brown, Jeanine ^a   Dinits Pensy, Mara Y ^a   Dilsizian, Vasken ^a,c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

Chronic kidney disease; Fluorodeoxyglucose; Glomerular filtration rate; Myocardial metabolism; Positron emission tomography; Uremic cardiomyopathy

Indexed keywords

CREATININE; FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE TOLERANCE TEST; GLUCOSE UTILIZATION; HEART LEFT ATRIUM; HEART MUSCLE METABOLISM; HEART WORK; HUMAN; IMAGING SYSTEM; MALE; MEASUREMENT; METABOLIC DISORDER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ADULT; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; FLUORODEOXYGLUCOSE F18; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; MYOCARDIUM; PILOT PROJECTS; POSITRON-EMISSION TOMOGRAPHY; UREMIA; YOUNG ADULT;

EID: 77954195702     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000318227     Document Type: Article

References (35)

1. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS: Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047. (Pubitemid 350074801)
2. Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S: Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 2001; 134: 629-636.
3. Meier-Kriesche HU, Baliga R, Kaplan B: Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation. Transplantation 2003; 75: 1291-1295.
4. Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, Salem DN, Levey AS, Sarnak MJ: Chronic kidney disease as a risk factor for cardiovascular disease and all cause mortality: a pooled analysis of community based studies. J Am Soc Nephrol 2004; 15: 1307-1315.
5. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305.
6. Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, Barre PE: Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 1995; 47: 186-192.
7. Hayashi SY, Rohani M, Lindholm B, Brodin LA, Lind B, Barany P, Alvestrand A, Seeberger A: Left ventricular function in patients with chronic kidney disease evaluated by colour tissue Doppler velocity imaging. Nephrol Dial Transplant 2006; 21: 125-132.
8. Ahmed A, Rich MW, Sanders PW, Perry GJ, Bakris GL, Zile MR, Love TE, Aban IB, Shlipak MG: Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study. Am J Cardiol 2007; 99: 393-398.
9. Mall G, Huther W, Schneider J, Lundin P, Ritz E: Diffuse intermyocardiocytic fibrosis in uraemic patients. Nephrol Dial Transplant 1990; 5: 39-44.
10. Amann K, Wiest G, Zimmer G, Gretz N, Ritz E, Mall G: Reduced capillary density in the myocardium of uremic rats: a stereological study. Kidney Int 1992; 42: 1079-1085.
11. Amann K, Breitbach M, Ritz E, Mall G: Myocyte/ capillary mismatch in the heart of uremic patients. J Am Soc Nephrol 1998; 9: 1018-1022.
12. Stanley WC: Cardiac energetics during ischemia and the rationale for metabolic interventions. Coron Artery Dis 2001; 12:S3-S7.
13. van der Vusse GJ, Stam H: Lipid and carbohydrate metabolism in the ischemic heart. Basic Res Cardiol 1987; 82: 149-153.
14. Tyralla K, Amann K: Morphology of the heart and arteries in renal failure. Kidney Int 2003; 63:S80-S83.
15. Nishimura M, Tsukamoto K, Hasebe N, Tamaki N, Kikuchi K, Ono T: Prediction of cardiac death in hemodialysis patients by myocardial fatty acid imaging. J Am Coll Cardiol 2008; 51: 139-145.
16. Aoki J, Ikari Y, Nakajima H, Mori M, Sugimoto T, Hatori M, Tanimoto S, Amiya E, Hara K: Clinical and pathologic characteristics of dilated cardiomyopathy in hemodialysis patients. Kidney Int 2005; 67: 333-340.
17. Mark PB, Johnston N, Goenning BA, Foster JE, Blyth KG, Martin TN, Steedman T, Dargie HJ, Jardine AG: Redefinition of uremic cardiomyopathy by contrast enhanced cardiac magnetic resonance imaging. Kidney Int 2006; 69: 1839-1845.
18. Pizzarelli F, Dattolo P, Ferdeghini EM, Morales MA: Parameters derived by ultrasonic myocardial characterization in dialysis patients are associated with mortality. Kidney Int 2005; 68: 1320-1325.
19. Patlak CS, Blasberg RG, Fenstermacher JD: Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983; 3: 1-7.
20. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J: A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612.
21. Laine H, Katoh C, Luotolahti M, Yki-Järvinen H, Kantola I, Jula A, Takala TO, Ruotsalainen U, Iida H, Haaparanta M, Nuutila P, Knuuti J: Myocardial oxygen consumption is unchanged but efficiency is reduced in patients with essential hypertension and left ventricular hypertrophy. Circulation 1999; 100: 2425-2430.
22. Schiffrin EL, Lipman ML, Mann JF: Chronic kidney disease: effects on the cardiovascular system. Circulation 2007; 116: 85-97.
23. National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39:S1-S266.
24. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, Mc-Cullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW: Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003; 108: 2154-2169. (Pubitemid 37337595)
25. Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, McAlister F, Garg AX: Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 2006; 17: 2034-2047.
26. Morita K, Katoh C, Yoshinaga K, Noriyasu K, Mabuchi M, Tsukamoto T, Kageyama H, Shiga T, Kuge Y, Tamaki N: Quantitative analysis of myocardial glucose utilization in patients with left ventricular dysfunction by means of 18 F-FDG dynamic positron tomography and three-compartment analysis. Eur J Nucl Med Mol Imaging 2005; 32: 806-812.
27. Taylor M, Wallhaus TR, Degrado TR, Russell DC, Stanko P, Nickles RJ, Stone CK: An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thiaheptadecanoic acid and [18F]FDG in patients with congestive heart failure. J Nucl Med 2001; 42: 55-62.
28. Vitale GD, deKemp RA, Ruddy TD, Williams K, Beanlands RS: Myocardial glucose utilization and optimization of [18]F-FDG PET imaging in patients with non-insulindependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction. J Nucl Med 2001; 42: 1730-1736.
29. Tillisch JH, Brunken R, Marshall R, Schwaiger M, Mandelkern M, Phelps M, Schelbert H: Reversibility of cardiac wallmotion abnormalities predicted by positron tomography. N Engl J Med 1986; 314: 884-888.
30. Dilsizian V, Fink J: Deleterious effect of altered myocardial fatty acid metabolism in kidney disease. J Am Coll Cardiol 2008; 51: 146-148.
31. Nishimura M, Murase M, Hashimoto T, Kobayashi H, Yamazaki S, Imai R, Okino K, Fujita H, Inoue N, Takahashi H, Ono T: Insulin resistance and impaired myocardial fatty acid metabolism in dialysis patients with normal coronary arteries. Kidney Int 2006; 69: 553-559.
32. Penpargkul S, Kuziak J, Scheuer J: Effect of uremia upon carbohydrate metabolism in isolated perfused rat heart. J Mol Cell Cardiol 1975; 7: 499-511.
33. Kates AM, Herrero P, Dence C, Soto P, Srinivasan M, Delano DG, Ehsani A, Gropler RJ: Impact of aging on substrate metabolism by the human heart. J Am Coll Cardiol 2003; 41: 293-299.
34. Neely JR, Morgan HE: Relationship between carbohydrate metabolism and energy balance of heart muscle. Ann Rev Physiol 1974; 36: 413-459.
35. Dávila-Román VG, Vedala G, Herrero P, De las Fuentes L, Rogers JG, Kelly DP, Gropler RJ: Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy. J Am Coll Cardiol 2002; 40: 271-277.